Private Equity Firm to Acquire Mallinckrodt Baker for $280 Million

Covidien has agreed to sell its Mallinckrodt Baker unit, a maker of high-purity lab and electronic chemicals, to private equity firm New Mountain Capital (New York) for $280 million. New Mountain says it will establish a strategic platform in specialty chemicals and materials. Former Rohm and Haas chairman and CEO Raj Gupta, is serving as a senior advisor to New Mountain....

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers